The Neuro Experience

How Cancer Treatment Is Destroying Men’s Sexual Function | Dr. Shawn Zimberg

5 snips
Dec 16, 2025
Dr. Shawn Zimberg, a board-certified radiation oncologist and medical director at Advanced Radiation Centers of New York, shares crucial insights on prostate cancer care. He discusses the overtreatment crisis, emphasizing the importance of genomic testing to distinguish between aggressive and indolent tumors. Zimberg critiques PSA screening, reveals cadaver study findings on prostate cancer prevalence, and introduces the revolutionary BioProtect balloon spacer, which he has pioneered. He also explores the role of radiation therapy and innovative treatment strategies for stage 4 cancer.
Ask episode
AI Snips
Chapters
Transcript
Episode notes
INSIGHT

Prostate Cancer Is A Spectrum

  • Cadaver studies show many men harbor prostate cancer cells across ages without clinical disease.
  • Prostate cancer spans a spectrum from indolent to deadly, so detection doesn't equal lethal disease.
ADVICE

Establish PSA Baselines Early

  • Start PSA screening around age 50 or earlier with family history and track annual trends.
  • Use serial PSAs to compare changes rather than a single isolated value.
INSIGHT

PSA Needs Context

  • PSA level correlates with prostate volume, so raw PSA alone can mislead.
  • PSA density (PSA/volume) gives better context than PSA number alone.
Get the Snipd Podcast app to discover more snips from this episode
Get the app